Frontlight ResearchEarly access
Trial site
Plovdiv
- 5running trials
- 6closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease4 trials
- Familial hypercholesterolaemia3 trials
- Stroke3 trials
- Chronic myeloid leukaemia2 trials
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Myeloproliferative neoplasms1 trial
- Peripheral artery disease1 trial
- Schizophrenia1 trial
- Thalassaemia1 trial
- and 1 more
- Phase
- Phase 37 trials
- Phase 22 trials
- Phase 42 trials
- Status
- Active, not recruiting4 trials
- Completed4 trials
- Terminated2 trials
- Recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals11 trials
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Schizophrenia1 recruiting
Closed trials
Completed
Terminated
Completed
Completed
Completed
Terminated
Site data: ClinicalTrials.govUpdated 15 Nov 2026